Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-01-19

Clinical Trial Update: Bromelain, Comosain as a New Drug for Treating and Preventing Various Types of Cancer in the Humans [Phase 2]

View source ↗

Summary

Phase 2 trial update on Bromelain and Comosain as a new cancer drug for treating and preventing various cancers; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bromelain (bromelain)
  • Comosain (comosain)

Snippet

Sponsor: Oeyama-Moto Cancer Research Foundation | Conditions: Cancer | Phase 2 | Status: UNKNOWN